Mixed pivotal data on Dicerna rival to Alnylam drug sink stock
Mixed pivotal data on Dicerna rival to Alnylam drug sink [...]
Dicerna’s stock sinks after its Alnylam rival shows mixed data, stymieing approval filing
Dicerna’s stock sinks after its Alnylam rival shows mixed data, [...]
Study of dogs and cats sheds light on key immune pathways
Study of dogs and cats sheds light on key immune [...]
Amgen pauses FLT3 bispecific trial, resumes dosing in BCMA study
Amgen pauses FLT3 bispecific trial, resumes dosing in BCMA study [...]
Pitt’s inhalable anti-COVID nanobodies, inspired by llamas, ‘remarkably active’ against delta variant: study
Pitt’s inhalable anti-COVID nanobodies, inspired by llamas, ‘remarkably active’ against [...]
Sage Therapeutics axes 2 zuranolone trials deemed unnecessary for approval in depression
Sage Therapeutics axes 2 zuranolone trials deemed unnecessary for approval [...]
Takeda allies with Frazier to spin out late-phase norovirus vaccinei
Takeda allies with Frazier to spin out late-phase norovirus vaccinei [...]
Ardelyx’s FDA rejection points to long path back for CKD drug
Ardelyx’s FDA rejection points to long path back for CKD [...]
Surprise! Pfizer jumps the queue and leaps into RSV vax contention as COVID helps turbo charge work
Surprise! Pfizer jumps the queue and leaps into RSV vax [...]
Rakuten Medical rakes in $166M series D following drug-device combo’s approval in Japan
Rakuten Medical rakes in $166M series D following drug-device combo’s [...]